137 related articles for article (PubMed ID: 28934904)
21. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
22. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
Krummenacher C; Diggelmann H; Acha-Orbea H
J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
[TBL] [Abstract][Full Text] [Related]
23. In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells.
Ferrero I; Anjuère F; MacDonald HR; Ardavín C
Blood; 1997 Sep; 90(5):1943-51. PubMed ID: 9292528
[TBL] [Abstract][Full Text] [Related]
24. Non-exclusive Fas control and age dependence of viral superantigen-induced clonal deletion in lupus-prone mice.
Papiernik M; Pontoux C; Golstein P
Eur J Immunol; 1995 Jun; 25(6):1517-23. PubMed ID: 7542196
[TBL] [Abstract][Full Text] [Related]
25. In vivo T cell response to viral superantigen. Selective migration rather than proliferation.
Le Bon A; Lucas B; Vasseur F; Penit C; Papiernik M
J Immunol; 1996 Jun; 156(12):4602-8. PubMed ID: 8648102
[TBL] [Abstract][Full Text] [Related]
26. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens.
Beutner U; Kraus E; Kitamura D; Rajewsky K; Huber BT
J Exp Med; 1994 May; 179(5):1457-66. PubMed ID: 8163931
[TBL] [Abstract][Full Text] [Related]
27. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
Pullen AM; Bogatzki LY
J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
[TBL] [Abstract][Full Text] [Related]
28. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
29. Transmission of an Mls-1a-like superantigen to BALB/c mice by foster-nursing on F1 Mls-1bxa mothers. Sex-influenced onset of clonal deletion.
Piazzon I; Goldman A; Torello S; Nepomnaschy I; Deroche A; Dran G
J Immunol; 1994 Aug; 153(4):1553-62. PubMed ID: 7913941
[TBL] [Abstract][Full Text] [Related]
30. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
31. Mls-1 and Mls-2 superantigens do not control susceptibility to collagen-induced arthritis in HI and HII mice.
Roger T; Boudaly S; Couderc J; Seman M
Immunology; 1993 Dec; 80(4):661-3. PubMed ID: 8307618
[TBL] [Abstract][Full Text] [Related]
32. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
33. Neonatal deletion and selective expansion of mouse T cells by exposure to rabies virus nucleocapsid superantigen.
Lafon M; Scott-Algara D; Marche PN; Cazenave PA; Jouvin-Marche E
J Exp Med; 1994 Oct; 180(4):1207-15. PubMed ID: 7931058
[TBL] [Abstract][Full Text] [Related]
34. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
[TBL] [Abstract][Full Text] [Related]
35. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
36. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
[TBL] [Abstract][Full Text] [Related]
37. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
38. A maternally inherited superantigen encoded by a mammary tumour virus.
Marrack P; Kushnir E; Kappler J
Nature; 1991 Feb; 349(6309):524-6. PubMed ID: 1846947
[TBL] [Abstract][Full Text] [Related]
39. Mouse endogenous superantigens: Ms and Mls-like determinants encoded by mouse retroviruses.
Hodes RJ; Abe R
Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1F. PubMed ID: 18432642
[TBL] [Abstract][Full Text] [Related]
40. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
